In addition, other Alzheimer’s disease relevant biomarkers including tau isoforms, neurofilament light and glial fibrillary acidic protein were not available for both cohorts at the time of the analysis. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.